+91-9696969696
IndiaMART is set to sustain strong growth momentum as businesses.
Edelweiss has given a ‘buy’ rating on IndiaMART InterMESH with a target price of Rs 1,900.
INVESTMENT RATIONALE
IndiaMART InterMESH (IndiaMART), India’s largest online B2B product and services platform, is set to sustain strong growth momentum as businesses are increasingly leveraging online channels for efficient procurement. A large and growing number of buyers and suppliers on the platform are driving up business enquiries, further increasing its attractiveness. This should continue to lift realisations and lure more paying customers, leading to a revenue CAGR of 24% over FY19–21. Given its high operating leverage, IndiaMARTNSE 0.34 % would clock CAGRs in EBITDA of 51% and PAT of 50% over the period.
“We see value in the stock owing to high entry barriers, network effect-driven pricing power, and negative working capital (INR7.5bn cash on books),” the brokerage said.
Network effect driving enquiries
“We are seeing a strong network effect at play. Growth in suppliers is luring more buyers and driving business enquiries, which in turn is attracting more sellers too. With a meagre 2.4% of the total suppliers as paying suppliers, and strong 59% CAGR in enquiries over FY16–19, we expect paying customers to continue to grow well,” the brokerage said
Investors view disruption risk for IndiaMART from the emergence of well-funded players. “It concerns us little since the so-called rivals operate in a narrow space and are far from gaining critical mass, whereas IndiaMART largely deals in long-tail products, wherein competition might affect only later. Besides, IndiaMART is building new businesses in payments, SaaS, and credit, which may create additional moats,” it said.
“We believe IndiaMART is on the cusp of strong profit growth momentum led by revenue growth and high operating leverage. Deferred revenue of INR6.1bn – 1.1x of TTM – provides strong visibility. The stock’s current valuation at 24 times FY21E P/E is attractive vis-a-vis growth prospects in our view. We are initiating coverage with a ‘buy’ and a target price of Rs 1,900, valuing it at 33 times Q3FY21E EPS,” the brokerage said.